Nasdaq: ENGN, ENGNW
enGene Therapeutics insiders
The officers, directors and 10% owners of enGene Therapeutics Inc. who hold the most stock, valued at the live ENGN price.
$1.76
ENGN today −$90K (−4.86%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their ENGN stock
- $5.4M
- Market value
- $118M
- Held by ranked insiders
- 4.56%
Insiders by value of ENGN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | De Solidarite Des Travailleurs Du Quebec Fonds | 10% owner | 3,036,153 | $5.3M | 4.53% | 13819th |
| 2 | Philip Astley-Sparke | Director | 20,000 | $35K | <0.1% | 4212th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for enGene Therapeutics; see each profile for the filing.